Yahoo
NasdaqGS - Delayed Quote USD

Alnylam Pharmaceuticals, Inc. (ALNY)

266.11 +1.61 (+0.61%)
At close: September 4 at 4:00:01 PM EDT
263.16 -2.95 (-1.11%)
After hours: September 4 at 7:54:55 PM EDT
Trade ALNY on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
4,804,182
3,713,937
2,248,243
1,828,292
1,037,418
Cost of Revenue
977,450
681,871
323,370
310,406
168,817
Gross Profit
3,826,732
3,032,066
1,924,873
1,517,886
868,601
Operating Expense
2,826,955
2,530,488
2,101,758
1,800,061
1,653,673
Operating Income
999,777
501,578
-176,885
-282,175
-785,072
Net Non Operating Interest Income Expense
-174,147
-141,157
-19,866
-25,660
-131,160
Other Income Expense
-59,342
-37,269
-180,624
-125,682
-210,761
Pretax Income
766,288
323,152
-377,375
-433,517
-1,126,993
Tax Provision
-8,423
9,405
-99,218
6,725
4,163
Net Income Common Stockholders
774,711
313,747
-278,157
-440,242
-1,131,156
Diluted NI Available to Com Stockholders
774,711
313,747
-278,157
-440,242
-1,131,156
Basic EPS
5.87
2.39
-2.18
-3.52
-9.30
Diluted EPS
5.74
2.33
-2.18
-3.52
-9.30
Basic Average Shares
132,548.50
131,004
127,651
124,906
121,689
Diluted Average Shares
138,731
134,684
127,651
124,906
121,689
Total Operating Income as Reported
999,777
501,578
-176,885
-282,175
-785,072
Rent Expense Supplemental
215,045
193,435
169,909
145,687
131,967
Total Expenses
3,804,405
3,212,359
2,425,128
2,110,467
1,822,490
Net Income from Continuing & Discontinued Operation
774,711
313,747
-278,157
-440,242
-1,131,156
Normalized Income
801,578.40
357,227.41
-150,072.30
-354,968.61
-969,555.97
Interest Income
110,052
111,470
121,992
95,561
24,808
Interest Expense
284,199
252,627
141,858
121,221
155,968
Net Interest Income
-174,147
-141,157
-19,866
-25,660
-131,160
EBIT
1,050,487
575,779
-235,517
-312,296
-971,025
EBITDA
1,105,248
631,437
-178,847
-258,242
-926,557
Reconciled Cost of Revenue
977,450
681,871
323,370
310,406
168,817
Reconciled Depreciation
54,761
55,658
56,670
54,054
44,468
Net Income from Continuing Operation Net Minority Interest
774,711
313,747
-278,157
-440,242
-1,131,156
Total Unusual Items Excluding Goodwill
-44,779
-44,779
-173,792
-107,941
-204,557
Total Unusual Items
-44,779
-44,779
-173,792
-107,941
-204,557
Normalized EBITDA
1,150,027
676,216
-5,055
-150,301
-722,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-17,911.60
-1,298.59
-45,707.30
-22,667.61
-42,956.97
12/31/2022 - 6/1/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: